| Prev Close | 56.21 |
| Day Low/High | 53.16 / 55.41 |
| 52 Wk Low/High | 28.00 / 62.04 |
Charles Schwab Corporation (SCHW)
53.29
NYSE
| Exchange | NYSE |
| Shares Outstanding | 1797.21B |
| Market Cap | 101.02B |
| P/E Ratio | 27.55 |
| Div & Yield | N.A. (N.A) |
Latest News
PulteGroup Is in a Prime Position as New Housing Demand Grows
This is one of few homebuilder equities that did not have a big move up in 2020 and the stock is cheap.
How Willing Are Traders to Chase in This Market?
I view the trading action as opportunistic rather than problematic.
Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook
Markets have certainly recovered nicely off of the lows of late September. Now, here in mid-October, it feels like it did that cold night back in 1980-something. The wolves are visible and noisy.
I Let You Know About These Great Opportunities -- Now I Have Another
Let's see how Affiliated Managers Group could bring great returns.
Does the Surge in Retail Traders Signal an Inevitable Market Collapse?
With the elimination of commissions, you can 'play' for free as long as you have capital.
Retail Traders Gone Wild
Wow... the data in this chart excludes Robinhood, Fidelity and a few others... Retail trading in June was largest ever GS: The top 4 online brokers ( , , , ) logged 8,079,000, the first time over 8M daily trades per day. July activity looks to excee...
Stop Rooting Against Your Stocks
The hardest part about living with covered calls is knowing that you might miss upside that exceeds your maximum net exit price -- but here are the pluses.
Jim Cramer: Non-Traditional Banks Are Starting to Pull Away From the ETFs
Overall, the banks failed you again. But the future for two of them is much brighter than the past.
A Complete Review of the Past Week's Macroeconomic Developments
Here is a summary of this week's major macroeconomic events: The Positives 1) Moderna , while still having to progress thru phase 3 trials, reported positive antibody results from phase 1 data and brings us a step closer to that hoped for vaccine....
Charles Is Looking Like a Good Option
Charles Schwab is open for business and gaining market share.
We'll Be Checking on These Corporate Earnings Next Week
Next week the June quarter earnings season maelstrom kicks off with 115 companies, including 32 S&P 500 constituents, reporting their latest quarterly results. In recent days we've seen a number of companies up their outlook for the quarter but we'v...
It's Not a Safe Bet but Ascena Retail Has a Shot at Survival
The company wants to stave off a hostile takeover by an acquirer seeking to utilize the company's tax-loss carryforwards.
It's Time to Take Stock of Schwab
The long-term record of Charles Schwab tells of its future value; its current price does not.
Divining Earnings, Stunning Rebound, Trading Amazon
Are the markets ready for a pause in this dramatic rebound? We are several weeks behind Europe in battling this pandemic and U.S. numbers are far worse. Time will tell.
A Day to Consider Charles
Charles Schwab is high-quality, predictable over the long run, and exactly the type of stock to own in a major market sell-off like the one on March 9.
Jim Cramer: The Market Took a Breather. Expect More to Come
While some 'pruning' can be necessary, Thursday was a strange day to get clipped.
Three Strategies for Income Investors
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
Consumer Spending
Kathy Jones, Chief Fixed Income Strategist at Charles Schwab , sums things up rather nicely... The sum of today's reports show consumer spending steady and import prices rising. Fed stays on hold while inflation inches higher. — Kathy Jones (@KathyJ...
Interpreting the U.S./China Trade Deal, Tax Cuts 2.0, Aerospace Stocks
Does such a large increase in Chinese spending on U.S. 'stuff' give reason to doubt that future action lives up to words on a page (or 86 pages for that matter)?
I Talk a Lot About Stocks' Performance -- Now I'll Talk About Mine
Here's a look back at how my recommendations worked out.
Big Merger Monday Conjures Up Thoughts of Potential Biotech Targets
The planned acquisition of The Medicines Company by Novartis spurs prospects of other deals in the drug business.
Jim Cramer: How Robinhood Is Disrupting the Trading Landscape
Robinhood is bringing a whole new generation of traders into the fold.
I Got Richer By Going Broke(r)
Unlike most others, I saw AMTD's huge drop as a buying opportunity, and now look at how it turned out.
My Takeaways
* A broad-based gain today * There is a narrative for every Deal and every Bull Market -- but it always changes and sometimes it's faux (e.g. Schwab/TD Ameritrade) The steady and relentless market advance of the last seven weeks continued today. We ...
Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not
We're seeing lots of companies snapping up their peers, and the market is applauding.
